← Eichor
Study identifier: NCT06468852 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

GDFT on the Postoperative Outcome in Head and Neck Cancer Surgery

Condition: Postoperative Complications  ·  Sponsor: Beijing Tongren Hospital

PhaseNA
Planned participants340
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate whether goal-directed fluid therapy (GDFT) can improve the postoperative recovery in patients undergoing head and neck cancer surgery. It aims to answer is: • Whether GDFT can reduce the occurrence of serious postoperative complications? Researchers will compare GDFT protocol to a standard conventional fluid therapy in head and neck cancer surgery to see if GDFT strategy works to improve the postoperative recovery. Participants will * Receive GDFT protocol or a conventional fluid therapy during the surgery. * Be continuously follow-up during hospitalization and after discharge to record the occurrence of postoperative complications.

This description comes directly from the study's public registry record.

Talk to the study team

Xuan Liang, master  ·  +8613810261846  ·  doctor_xuan@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing tongren Hospital, Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06468852